Full Press Release Details
Aurora Cannabis Announces Date of Annual
TSX: ACB | NYSE: ACB
EDMONTON, Sept. 20, 2019 /CNW/ - Aurora
Cannabis Inc. (the "Company" or "Aurora") (NYSE | TSX: ACB), the Canadian company defining the
future of cannabis worldwide, today announced that it will hold its Annual General Meeting of shareholders (the "Meeting")
on Friday, November 8th, 2019 at 10:00am MT. All registered shareholders are welcome to attend at the Renaissance Hotel
located at 4236 36 St E, Edmonton International Airport, AB T9E 0V4. In conjunction with the Meeting, Aurora has filed its Information
Circular and related proxy materials which are available for download under its profile on both SEDAR and EDGAR.
The Company also announced today that it has
granted an aggregate of 2,114,703 stock options, 33,186 deferred share units ("DSUs") and 376,895 restricted share units
("RSUs") to directors and officers of the Company. The stock options are exercisable at a price of $7.91 per share for
a period of five years from the date of grant. Both options and RSUs vest annually over 36 months and the DSUs vest quarterly over
Headquartered in Edmonton, Alberta, Canada
with funded capacity in excess of 625,000 kg per annum and sales and operations in 25 countries across five continents, Aurora
is one of the world's largest and leading cannabis companies. Aurora is vertically integrated and horizontally diversified across
every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis
and hemp production, derivatives, high value-add product development, home cultivation, wholesale and retail distribution.
Highly differentiated from its peers, Aurora
has established a uniquely advanced, consistent and efficient production strategy, based on purpose-built facilities that integrate
leading-edge technologies across all processes, defined by extensive automation and customization, resulting in the massive scale
production of high-quality consistent product. Designed to be replicable and scalable globally, our production facilities are designed
to produce cannabis at significant scale, with high quality, industry-leading yields, and low-per gram production costs. Each of
Aurora's facilities is built to meet European Union Good Manufacturing Practices ("EU GMP") standards. Certification
has been granted to Aurora's first production facility in Mountain View County, the MedReleaf Markham facility, and its wholly
owned European medical cannabis distributor Aurora Deutschland. All Aurora facilities are designed and built to the EU GMP standard.
In addition to the Company's rapid organic
growth and strong execution on strategic M&A, which to date includes 17 wholly owned subsidiary companies - MedReleaf,
CanvasRX, Peloton Pharmaceutical, Aurora Deutschland, H2 Biopharma, BC Northern Lights, Larssen Greenhouses, CanniMed Therapeutics,
Anandia, HotHouse Consulting, MED Colombia, Agropro, Borela, ICC Labs, Whistler, Chemi Pharmaceutical, and Hempco - Aurora
is distinguished by its reputation as a partner and employer of choice in the global cannabis sector, having invested in and established
strategic partnerships with a range of leading innovators, including: Radient Technologies Inc. (TSXV: RTI), Cann Group Ltd. (ASX:
CAN), Micron Waste Technologies Inc. (CSE: MWM), Choom Holdings Inc. (CSE: CHOO), CTT Pharmaceuticals (OTCC: CTTH), Alcanna Inc.
(TSX: CLIQ), High Tide Inc. (CSE: HITI), EnWave Corporation (TSXV: ENW), Capcium Inc. (private), Evio Beauty Group (private), and
Wagner Dimas (private).
Aurora's Common Shares trade on the TSX and
NYSE under the symbol "ACB", and is a constituent of the S&P/TSX Composite Index.
For more information about Aurora, please visit
our investor website, investor.auroramj.com
Aurora Cannabis Inc.
Forward Looking Statements .
This news release includes statements containing
certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements").
Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect",
"project", "intend", "believe", "anticipate", "estimate", "may", "will",
"potential", "proposed" and other similar words, or statements that certain events or conditions "may"
or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making
the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based
on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties
and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements.
The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking
statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX, NYSE nor their applicable Regulation
Services Providers (as that term is defined in the policies of the Toronto Stock Exchange and New York Stock Exchange) accept responsibility
for the adequacy or accuracy of this release.
original content to download multimedia:http://www.prnewswire.com/news-releases/aurora-cannabis-announces-date-of-annual-general-meeting-300922644.html
SOURCE Aurora Cannabis Inc.
View original content to download multimedia:
For further information: For Media: Heather MacGregor, +1.416.509.5416,
heather.macgregor@auroramj.com; For Investors: Rob Kelly, +1.647.331.7228, rob.kelly@auroramj.com
CO: Aurora Cannabis Inc.
CNW 17:00e 20-SEP-19